Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
BIOFORCE NANOSCIENCES HOLDINGS, INC.BioForce Nanosciences Reports No Revenue and Increased Losses in Q2 2025
enCore Energy Corp.enCore Energy Reports Q2 2025 Financial Results with Revenue Decline and Improved Net Loss
Bank First CorpBank First Corporation Reports Q2 2025 Financial Results with $16.9 Million Net Income
Excelerate Energy, Inc.Excelerate Energy Reports 11.6% Revenue Growth in Q2 2025 Amid Acquisition Costs
THUNDER MOUNTAIN GOLD INCThunder Mountain Gold Reports Increased Losses and Financial Developments for Q2 2025
Holistic Asset Finance Group Co., Ltd.Holistic Asset Finance Group Reports 503% Revenue Growth but Faces Net Loss in Latest Financial Filing
BioCardia, Inc.BioCardia Reports Revenue Decline and Increased Losses in Q2 2025
MNTN, Inc.MNTN Reports 24.9% Revenue Growth to $68.5 Million in Q2 2025, Despite Increased Net Loss
Mediaco Holding Inc.Mediaco Holding Inc. Reports 19% Revenue Growth to $31.2 Million in Latest Quarter
SONIDA SENIOR LIVING, INC.Sonida Senior Living Reports 33.2% Revenue Growth to $93.5 Million in Q2 2025
TSS, Inc.TSS, Inc. Reports 262% Revenue Growth to $43.97 Million in Latest Quarter
UFP TECHNOLOGIES INCUFP Technologies Reports 37.2% Revenue Growth in Q2 2025, Net Income Increases to $17.2 Million
Theriva Biologics, Inc.Theriva Biologics Reports $13.1 Million Net Loss for Q2 2025 Amid Rising Expenses
Protara Therapeutics, Inc.Protara Therapeutics Reports $14.96 Million Net Loss in Q2 2025, Increased R&D Expenses
Aptevo Therapeutics Inc.Aptevo Therapeutics Reports $12.6 Million Net Loss, Expands Product Pipeline
4D Molecular Therapeutics, Inc.4D Molecular Therapeutics Reports $54.7 Million Net Loss in Q2 2025
Sphere Entertainment Co.Sphere Entertainment Co. Reports $151.8 Million Net Income in Q2 2025
TELEPHONE & DATA SYSTEMS INC /DE/Telephone and Data Systems Reports Revenue Decline but Increased Net Income in Q2 2025
ARRAY DIGITAL INFRASTRUCTURE, INC.Array Digital Infrastructure Reports Mixed Q2 Results Amid Strategic Changes and Wireless Sale
Apogee Therapeutics, Inc.Apogee Therapeutics Reports $66.1 Million Net Loss in Q2 2025 Amid Increased R&D Expenses
Roivant Sciences Ltd.Roivant Sciences Reports Significant Revenue Decline and Increased Net Loss for Q2 2025
Karyopharm Therapeutics Inc.Karyopharm Therapeutics Reports $37.9M Revenue in Q2 2025, Faces Financial Challenges
MAIA Biotechnology, Inc.MAIA Biotechnology Reports 40% Improvement in Q2 Net Loss, Advances Clinical Trials
Immunovant, Inc.Immunovant Reports $120.6 Million Net Loss and Increased Operating Expenses for Q2 2025
WW INTERNATIONAL, INC.WW International Reports $12.2 Million Revenue Following Chapter 11 Emergence